PRISM BioLabLTD Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Dai Takehara
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 2.1% |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO
Dai Takehara (61 yo)
no data
Tenure
Mr. Dai Takehara is President, Chief Executive Officer & Director of PRISM BioLab Co.,LTD. since December 2016 and serves its Chairperson. He served as Chief Financial Officer at PRISM Pharma Co.,Ltd.Befo...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | no data | no data | 2.05% ¥ 326.7m | |
| GM of Administration | 2.1yrs | no data | no data | |
| Head of the Research & Development Department & Director | 2.5yrs | no data | no data | |
| Auditor | 5.8yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
2.5yrs
Average Tenure
55yo
Average Age
Experienced Board: 206A's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.